Delivery of Exogenous miR-124 to Glioblastoma Multiform Cells by Wharton’s Jelly Mesenchymal Stem Cells Decreases Cell Proliferation and Migration, and Confers Chemosensitivity
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Delivery of Exogenous miR-124 to Glioblastoma Multiform Cells by Wharton’s Jelly Mesenchymal Stem Cells Decreases Cell Proliferation and Migration, and Confers Chemosensitivity
Authors
Keywords
Glioma, MiR-124, Temozolomide, Mesenchymal stem cells, Warton’s jelly
Journal
Stem Cell Reviews and Reports
Volume 14, Issue 2, Pages 236-246
Publisher
Springer Nature
Online
2017-11-28
DOI
10.1007/s12015-017-9788-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of mesenchymal stem cells’ secretome on glioblastoma pathophysiology
- (2017) Joana Vieira de Castro et al. Journal of Translational Medicine
- Enhanced neuro-therapeutic potential of Wharton's Jelly–derived mesenchymal stem cells in comparison with bone marrow mesenchymal stem cells culture
- (2016) Katarzyna Drela et al. CYTOTHERAPY
- Mesenchymal Stem Cells Deliver Exogenous MicroRNA-let7c via Exosomes to Attenuate Renal Fibrosis
- (2016) Bo Wang et al. MOLECULAR THERAPY
- Exosome Derived From Human Umbilical Cord Mesenchymal Stem Cell Mediates MiR-181c Attenuating Burn-induced Excessive Inflammation
- (2016) Xiao Li et al. EBioMedicine
- The Effect of MicroRNA-124 Overexpression on Anti-Tumor Drug Sensitivity
- (2015) Shiau-Mei Chen et al. PLoS One
- MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras
- (2014) Zhumei Shi et al. NEURO-ONCOLOGY
- Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth
- (2013) Mark Katakowski et al. CANCER LETTERS
- miR-124 Inhibits STAT3 Signaling to Enhance T Cell–Mediated Immune Clearance of Glioma
- (2013) Jun Wei et al. CANCER RESEARCH
- Wharton’s Jelly-Derived Mesenchymal Stem Cells: Phenotypic Characterization and Optimizing Their Therapeutic Potential for Clinical Applications
- (2013) Dae-Won Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Characteristics of mesenchymal stem cells derived from Wharton's jelly of human umbilical cord and for fabrication of non-scaffold tissue-engineered cartilage
- (2013) Shuyun Liu et al. JOURNAL OF BIOSCIENCE AND BIOENGINEERING
- microRNA-124 Inhibits Migration and Invasion by Down-Regulating ROCK1 in Glioma
- (2013) Liwen An et al. PLoS One
- Mesenchymal Stem Cells from Human Umbilical Cord Express Preferentially Secreted Factors Related to Neuroprotection, Neurogenesis, and Angiogenesis
- (2013) Jui-Yu Hsieh et al. PLoS One
- Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell–derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity
- (2013) Jessian L Munoz et al. Molecular Therapy-Nucleic Acids
- Increased Expression of P-Glycoprotein and Doxorubicin Chemoresistance of Metastatic Breast Cancer Is Regulated by miR-298
- (2012) Lili Bao et al. AMERICAN JOURNAL OF PATHOLOGY
- MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF
- (2012) Chao Zou et al. CELL CYCLE
- Glioma Stem Cells: Their Role in Chemoresistance
- (2012) Ryosuke Yamada et al. World Neurosurgery
- Mesenchymal stem cells engineered for cancer therapy
- (2011) Khalid Shah ADVANCED DRUG DELIVERY REVIEWS
- Gap Junction-Mediated Import of MicroRNA from Bone Marrow Stromal Cells Can Elicit Cell Cycle Quiescence in Breast Cancer Cells
- (2011) P. K. Lim et al. CANCER RESEARCH
- miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion
- (2011) Adam Fowler et al. EUROPEAN JOURNAL OF CANCER
- MicroRNA therapeutics
- (2011) J A Broderick et al. GENE THERAPY
- MicroRNA-mediated conversion of human fibroblasts to neurons
- (2011) Andrew S. Yoo et al. NATURE
- MicroRNAs as therapeutic targets in cancer
- (2011) S. Patrick Nana-Sinkam et al. Translational Research
- Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells
- (2011) María Mittelbrunn et al. Nature Communications
- Mesenchymal stem cell-mediated cancer therapy: A dual-targeted strategy of personalized medicine
- (2011) Xu-Yong Sun World Journal of Stem Cells
- The Promise of MicroRNA Replacement Therapy
- (2010) A. G. Bader et al. CANCER RESEARCH
- Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells
- (2010) Nobuyoshi Kosaka et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Microvesicles Derived from Adult Human Bone Marrow and Tissue Specific Mesenchymal Stem Cells Shuttle Selected Pattern of miRNAs
- (2010) Federica Collino et al. PLoS One
- HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells
- (2009) Miroslava Matuskova et al. CANCER LETTERS
- MicroRNA-34a Inhibits Glioblastoma Growth by Targeting Multiple Oncogenes
- (2009) Y. Li et al. CANCER RESEARCH
- Emerging functions of microRNAs in glioblastoma
- (2009) Sean Lawler et al. JOURNAL OF NEURO-ONCOLOGY
- miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche
- (2009) Li-Chun Cheng et al. NATURE NEUROSCIENCE
- miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells
- (2008) Joachim Silber et al. BMC Medicine
- Targeting of the Bmi-1 Oncogene/Stem Cell Renewal Factor by MicroRNA-128 Inhibits Glioma Proliferation and Self-Renewal
- (2008) J. Godlewski et al. CANCER RESEARCH
- Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model
- (2008) Andrea Mohr et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): A proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases
- (2007) Dimitrios Karussis et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started